Cargando…
New cancers therapy through targeting Aldo-keto reductase family 1 member B10 with miRNAs
Autores principales: | He, Rong-Zhang, Jiang, Jing, Luo, Di-Xian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798958/ https://www.ncbi.nlm.nih.gov/pubmed/35117772 http://dx.doi.org/10.21037/tcr-19-2467 |
Ejemplares similares
-
Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment
por: Huang, Li, et al.
Publicado: (2016) -
Aldo-Keto Reductases in the Eye
por: Huang, Shun Ping, et al.
Publicado: (2010) -
Impact of cytotoxic chemotherapy on aldo-keto reductase family 1 member B10 expression
por: Robinson, Kathy, et al.
Publicado: (2023) -
Expression of Aldo-Keto Reductase Family 1 Member B10 in the Early Stages of Human Hepatocarcinogenesis
por: Tsuzura, Hironori, et al.
Publicado: (2014) -
Diagnostic value of aldo‑keto reductase family 1 member B10 in human nasopharyngeal carcinoma
por: Lu, Jinping, et al.
Publicado: (2023)